77
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch

, , , , , , , , & show all
Pages 607-621 | Published online: 03 Feb 2012

References

  • AguilarJCRodriguezEGVaccine adjuvants revisitedVaccine200725193752376217336431
  • ErikçiEGurselMGürselIDifferential immune activation following encapsulation of immunostimulatory CpG oligodeoxynucleotide in nanoliposomesBiomaterials20113261715172321112627
  • HafnerAMCorthésyBTextorMMerkleHPTuning the immune response of dendritic cells to surface-assembled poly(I:C) on microspheres through synergistic interactions between phagocytic and TLR3 signalingBiomaterials201132102651266121216459
  • ZhangZTongchusakSMizukamiYInduction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen deliveryBiomaterials201132143666367821345488
  • HeffernanMJZaharoffDAFallonJKSchlomJGreinerJWIn vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccinesBiomaterials201132392693220965561
  • AbbasAKMurphyKMSherAFunctional diversity of helper T lymphocytesNature199638366037877938893001
  • Hernández-PandoROrozcoeHSampieriACorrelation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosisImmunology199689126338911136
  • BaisAGBeckmannILindemansJA shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesionsJ Clin Pathol200558101096110016189158
  • KiddPTh1/Th2 balance: the hypothesis, its limitations, and implications for health and diseaseAltern Med Rev20038322324612946237
  • StavnezerJImmunoglobulin class switchingCurr Opin Immunol1996821992058725943
  • SinghVKMehrotraSAgarwalSSThe paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergyImmunol Res199920214716110580639
  • GarcíaBESanzMLGatoJJFernándezJOehlingAIgG4 blocking effect on the release of antigen-specific histamineJ Investig Allergol Clin Immunol1993312633
  • ParhamPThe Immune System3rd edNew York, NYGarland Science2009
  • NordlyPMadsenHBNielsenHMFogedCStatus and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulatorsExpert Opin Drug Deliv20096765767219538037
  • HemmiHTakeuchiOKawaiTA Toll-like receptor recognizes bacterial DNANature2000408681374074511130078
  • ParkSRKimHAChunSKParkJBKimPHMechanisms underlying the effects of LPS and activation-induced cytidine deaminase on IgA isotype expressionMol Cells200519344545115995363
  • KinNWChenYStefanovEKGalloRLKearneyJFCathelin-related antimicrobial peptide differentially regulates T- and B-cell functionEur J Immunol201141103006301621773974
  • LiouCJTsengJA Chinese herbal medicine, fu-ling, regulates interleukin-10 production by murine spleen cellsAm J Chin Med200230455156012568282
  • LiouCJLiMLTsengJIntraperitoneal injection of ginseng extract enhances both immunoglobulin and cytokine production in miceAm J Chin Med2004321758815154287
  • LiuYKLinYLChenCHA unique and potent protein binding nature of liposome containing polyethylenimine and polyethylene glycol: a nondisplaceable propertyBiotechnol Bioeng201010861318132721192002
  • BennewitzNLBabenseeJEThe effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigenBiomaterials200526162991299915603794
  • CoombesAGMajorDWoodJMHockleyDJMinorPDDavisSSResorbable lamellar particles of polylactide as adjuvants for influenza virus vaccinesBiomaterials19981911–12107310819692806
  • MatzelleMMBabenseeJEHumoral immune responses to model antigen co-delivered with biomaterials used in tissue engineeringBiomaterials200425229530414585717
  • GhendonYMarkushinSAkopovaIKoptiaevaIKrivtsovGChitosan as an adjuvant for poliovaccineJ Med Virol201183584785221412793
  • JiangHLKangMLQuanJSThe potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunizationBiomaterials200829121931193918221992
  • KwongBLiuHIrvineDJInduction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapyBiomaterials201132225134514721514665
  • ChhibberSWadhwaSYadavVProtective role of liposome incorporated lipopolysaccharide antigen of Klebsiella pneumoniae in a rat model of lobar pneumoniaJpn J Infect Dis200457415015515329446
  • van SlootenMLStormGZoephelALiposomes containing interferon-gamma as adjuvant in tumor cell vaccinesPharm Res2000171424810714607
  • McGettrickAFO’NeillLAToll-like receptors: key activators of leucocytes and regulator of haematopoiesisBr J Haematol2007139218519317897294
  • RajputZIHuSHXiaoCWArijoAGAdjuvant effects of saponins on animal immune responsesJ Zhejiang Univ Sci B20078315316117323426
  • LinYLLiuYKTsaiNMA Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cellsNanomedicine2011 Epub June 24, 2011
  • ChowYHChiangBLLeeYLDevelopment of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genesJ Immunol19981603132013299570550
  • SutoANakajimaHHiroseKInterleukin 21 prevents antigen-induced IgE production by inhibiting germ line C(epsilon) transcription of IL-4-stimulated B cellsBlood2002100134565457312393685
  • MuellerCKeelerABraagSMenzTTangQFlotteTRModulation of Exaggerated-IgE Allergic Responses by Gene Transfer-mediated Antagonism of IL-13 and IL-17eMol Ther201018351151819935781
  • RegnströmKRagnarssonEGKöping-HöggårdMTorstenssonENyblomHArturssonPPEI – a potent, but not harmless, mucosal immuno-stimulator of mixed T-helper cell response and FasL-mediated cell death in miceGene Ther200310181575158312907949
  • KorsholmKSAggerEMFogedCThe adjuvant mechanism of cationic dimethyldioctadecylammonium liposomesImmunology2007121221622617302734
  • ChristensenDAggerEMAndreasenLVKirbyDAndersenPPerrieYLiposome-based cationic adjuvant formulations (CAF): past, present, and futureJ Liposome Res200919121119515003
  • GromméMNeefjesJAntigen degradation or presentation by MHC class I molecules via classical and non-classical pathwaysMol Immunol2002393–418120212200050
  • GodbeyWTWuKKMikosAGPoly(ethylenimine) and its role in gene deliveryJ Control Release1999602–314916010425321
  • AkincAThomasMKlibanovAMLangerRExploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesisJ Gene Med20057565766315543529
  • ChenJLiZHuangHImproved antigen cross-presentation by polyethyleneimine-based nanoparticlesInt J Nanomedicine20116778421289984
  • KitazoeMMurataHFutamiJProtein transduction assisted by polyethylenimine-cationized carrier proteinsJ Biochem2005137669370116002991
  • DidenkoVVNgoHBaskinDSPolyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodiesAnal Biochem2005344216817316095551